Olema Pharmaceuticals, Inc. (OLMA) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
OLMA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
OLMA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export OLMA earnings history in CSV or JSON format
Free sign-in required to download data
Olema Pharmaceuticals, Inc. (OLMA) Earnings Overview
As of May 8, 2026, Olema Pharmaceuticals, Inc. (OLMA) reported trailing twelve-month net income of -$162M, reflecting +15.0% year-over-year growth. The company earned $-1.78 per diluted share over the past four quarters.
Looking at the long-term picture, OLMA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2018.
Olema Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SRRK (-$409M net income), KYMR (-$315M net income, -794.4% margin), RVMD (-$1.37B net income), OLMA has comparable earnings metrics. Compare OLMA vs SRRK →
OLMA Earnings vs Peers
Earnings metrics vs comparable public companies
OLMA Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$162M | -25.5% | -$179M | $-1.87 | - | - |
| 2024 | -$129M | -34.0% | -$142M | $-2.20 | - | - |
| 2023 | -$97M | +7.8% | -$105M | $-2.14 | - | - |
| 2022 | -$105M | -47.4% | -$107M | $-2.62 | - | - |
| 2021 | -$71M | -221.4% | -$71M | $-1.79 | - | - |
| 2020 | -$22M | -412.5% | -$22M | $-0.58 | - | - |
| 2019 | -$4M | -96.4% | -$4M | $-0.11 | - | - |
| 2018 | -$2M | - | -$2M | $-0.16 | - | - |
See OLMA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OLMA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OLMA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOLMA — Frequently Asked Questions
Quick answers to the most common questions about buying OLMA stock.
Is OLMA growing earnings?
OLMA EPS stands at $-1.78, with +15.0% growth matching the 5-year CAGR of N/A. TTM net income is $-162M. Earnings trajectory remains consistent.
What are OLMA's profit margins?
Olema Pharmaceuticals, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are OLMA's earnings?
OLMA earnings data spans 2018-2025. The current earnings trend is +15.0% YoY. Historical data enables comparison across business cycles.